Tag Archives: AIA

USPTO Publishes Extensive Examination Guidelines for 35 U.S.C. 102 and 103

On February 14, 2013, the PTO published extensive Examination Guidelines for examination of applications filed after March 16, 2013, under 102 and 103 as amended by the AIA. Given the debates, if not confusion, that arose following the publication of … Continue reading

Posted in AIA Patent Reform, USPTO Practice and Policy | Tagged , , , , | 2 Comments

Top Ten Biotech IP Stories of 2012

I admit, I am a sucker for lists, esp. Top Ten Lists, and a few days ago, sat through a half hour of “local news” wherein the anchors breathlessly related the Top Ten Rhode Island News Stories of 2012. Well, … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , , , , | 2 Comments

USPTO Publishes Rule Package on AIA Administrative Trials

While this is primarily a biotechnology patent law blog, the USPTO’s high level of rule making activity deserves attention, as it will affect us all after the September 16th deadline for implementing many of the new features of the AIA … Continue reading

Posted in AIA Patent Reform | Tagged , , , , , , , | Leave a comment

PTO Rules on Pre-issuance Submissions by Third Parties

On July 17th, the USPTO released the rules that will govern the mandate in Section 8 of the AIA that requires the Office to provide for the submission by third parties of patents, published patent applications and other materials that … Continue reading

Posted in Patent Reform Legislation, USPTO Practice and Policy | Tagged , , , , , , , | 1 Comment